Dr. Stefano Silvoni is a Research Fellow in the Department of Cognitive and Clinical Neuroscience at the Central Institute of Mental Health, Mannheim, actively contributing to the “Learning and Brain Plasticity in Mental Disorder” research group. His work bridges clinical neuroscience and digital health interventions, focusing on neuroplasticity mechanisms in aging and cognitive disorders. His research spans Neuroscience , Clinical Neuroscience , and Neurorehabilitation , with specialized expertise in sensorimotor training , cognitive impairment , and digital therapeutics . Key investigations include developing adaptive home-based training systems using tablets and mobile applications to address mild cognitive impairment and frailty in elderly populations, leveraging neuroimaging to quantify cortical changes. Analysis of his 2019-2025 publications reveals a cohesive trajectory from clinical trial design to efficacy validation of sensorimotor interventions, emphasizing real-world applicability through home-based digital platforms. His work consistently integrates functional near-infrared spectroscopy (fNIRS) with clinical assessments to demonstrate neural and behavioral improvements in cognitive decline. Scientific awards: No awards or fellowships were documented in the source material. Advising and grants: The provided text contains no references to doctoral students, grant funding, or supervised research projects. Labs and teams: As a core member of the “Learning and Brain Plasticity in Mental Disorder” group, he collaborates on interdisciplinary studies combining cognitive neuroscience, geriatrics, and engineering to develop accessible interventions for mental health disorders.
Dr. Morris B Goldman is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Northwestern University's Feinberg School of Medicine. With over four decades of clinical and research experience, he specializes in severe mental illnesses, particularly psychosis, and has developed innovative approaches to early intervention and recovery. His work bridges clinical psychiatry, neuroscience, and endocrinology, with a focus on understanding the biological mechanisms underlying psychotic disorders. Dr. Goldman received his MD from the University of Pennsylvania in 1980 and completed his psychiatry residency at the University of Chicago Hospitals in 1984. He is board certified in Psychiatry by the American Board of Psychiatry and Neurology. Dr. Goldman's research spans several interconnected areas focused on severe mental illness. His early work examined the life-threatening water imbalance (polydipsia and hyponatremia) in chronic psychotic patients, leading to a NIH-sponsored fellowship in neuroendocrinology. He discovered a plausible mechanism involving disruption of anterior hippocampal regulation of hypothalamic-mediated neuroendocrine responses. More recently, he has focused on prepulse inhibition as a biomarker of schizophrenia and developed transcranial magnetic stimulation approaches to enhance this neural function. His clinical research has centered on early intervention for psychosis, culminating in the development of the Recovery from Early Psychosis Program (REPP), which takes a strength-based, developmentally-focused approach that has shown significantly better outcomes than standard early intervention services. Dr. Goldman's publication record demonstrates a consistent focus on understanding the biological mechanisms of psychosis while developing practical clinical interventions. His work bridges basic neuroscience with clinical application, particularly in water imbalance disorders among psychotic patients and the development of the REPP model for early psychosis intervention. His research shows an evolution from basic pathophysiological studies toward more applied clinical interventions that address the developmental needs of young people experiencing first-episode psychosis. Dr. Goldman has received numerous teaching and mentoring awards throughout his career: Outstanding Overall Psychiatry Resident Educator, Psychiatry and Behavioral Sciences, Northwestern University (2020) Outstanding Educator PGY-II Residents, University of Chicago Department of Psychiatry (2009, 2008, 2004) Best Doctors in America (2008) Mentor of the Year, Illinois Psychiatric Society (2004) Outstanding Educator, University of Chicago Department of Psychiatry (2002) Throughout his career, Dr. Goldman has been dedicated to training the next generation of clinicians and researchers in psychiatry. He has mentored numerous medical students, residents, and fellows, particularly focusing on helping them develop meaningful connections with patients suffering from severe mental illness. His Recovery from Early Psychosis Program (REPP) has received significant philanthropic support, allowing for the development of innovative strength-based, developmentally-focused interventions that have shown remarkable success in helping young people recover from first-episode psychosis. The program's emphasis on peer support, occupational therapy, and personalized recovery planning represents a significant departure from traditional approaches to early psychosis intervention. Dr. Goldman leads the Recovery from Early Psychosis Program (REPP) at Northwestern, which has grown substantially since its inception in 2017. The program now includes a multidisciplinary team of psychiatrists, social workers, occupational therapists, peer supporters, and researchers. REPP collaborates with the Focus Forward (F2) program, which promotes competitive employment and academic reintegration for patients. The program has developed innovative approaches including cognitive remediation through Brain HQ, group-based resiliency training, narrative and storytelling groups, and community-based activities to support recovery.
Yuta Senzai serves as an Assistant Professor in the Department of Neuroscience at Northwestern University's Feinberg School of Medicine, focusing on neural mechanisms of sleep and visual processing. His research bridges basic neuroscience with clinical implications for neurodevelopmental disorders. His educational background includes: MD from Kyoto University (2012) PhD from New York University (2018) Dr. Senzai's research explores how neural circuits generate cognitive processes during sleep, particularly REM sleep phenomena and sensorimotor integration in visual processing. His work employs advanced electrophysiological and behavioral techniques to investigate how the brain simulates actions during dreaming and how head movements modulate visual cortex activity. Affiliated with the Center for Autism and Neurodevelopment, his research has significant implications for understanding neurodevelopmental conditions. Analysis of his publication record reveals a cohesive trajectory examining neural dynamics across sleep-wake cycles, with increasing focus on cognitive aspects of REM sleep and naturalistic sensorimotor integration. His recent work demonstrates methodological sophistication in capturing neural activity during complex behaviors. No scientific awards are documented in the provided information. While specific advisees aren't listed, his position implies graduate student mentorship within Northwestern's neuroscience programs. Research is conducted through the Center for Autism and Neurodevelopment, providing access to interdisciplinary resources and clinical populations. His work likely involves collaborations with sleep medicine specialists and autism researchers, though specific grants aren't detailed in the profile.
Gordon MG Shepherd, MD, PhD is a Professor of Neuroscience at Northwestern University's Feinberg School of Medicine, where he leads a research laboratory focused on neural circuit organization in motor-frontal cortex. His work bridges cellular, synaptic, and systems neuroscience to understand the neural basis of motor control, executive functions, and working memory. Dr. Shepherd's research interests center on elucidating the functional 'wiring diagrams' of neocortical neurons in motor-frontal cortex. His laboratory applies multiple tools of quantitative synaptic circuit analysis, including laser scanning photostimulation microscopy based on glutamate uncaging and channelrhodopsin-2 excitation. His team investigates circuit-level mechanisms in mouse models of disease, including autism, Rett syndrome, epilepsy, and motor neuron diseases. They also develop software tools for imaging and electrophysiology applications ( www.scanimage.org , www.ephus.org ). His research portfolio demonstrates a consistent focus on cortical connectivity, synaptic organization, and motor control systems. The articles reflect an evolution from basic circuit mapping to increasingly sophisticated multiscale modeling approaches that integrate cellular, circuit, and behavioral data. His work spans molecular, cellular, and systems neuroscience with strong translational implications for neurological disorders. Dr. Shepherd has received significant recognition for his contributions to neuroscience: Javitz Neuroscience Investigator Award, NIH, NINDS (2023) Research Award, Evans Foundation (2011) Albert and Ellen Grass Faculty Award, Grass Foundation (2008-2010) Member, MBL Society (2010) Professionally, Dr. Shepherd serves as Associate Editor for Science Advances (2019-present) and on several editorial boards. He has held leadership positions including Chair of the Society for Neuroscience (2012) and serves on scientific advisory boards for the Emory-Udall Parkinson's Disease Center and NINDS. His laboratory contributes to the Northwestern University Interdepartmental Neuroscience Program (NUIN), which trains 20-25 PhD students annually through a six-year program involving laboratory rotations and thesis research. Dr. Shepherd's laboratory maintains active collaborations and develops computational tools that support neuroscience research community-wide. His work on cortical cells, circuits, and signals aims to understand the cellular mechanisms for motor control in behaving animals and how these are affected in neurological diseases that impair sensorimotor function.
Matthias Müller is a Professor and Chair of General Psychology and Methodology at the University of Leipzig, where he has held his position since April 2003. He is affiliated with the Faculty of Biosciences, Pharmacy and Psychology, and has previously served as Dean (2008-2011) and Vice Dean (2005-2008) of this faculty. He also served as Head of the Psychological Institute and board member of the Center for Cognitive Neuroscience at the University of Leipzig. University: University of Leipzig Faculty: Faculty of Biosciences, Pharmacy and Psychology Department: Department of General Psychology and Methodology Position: Chair/Professor since 2003 Previous leadership roles: Dean (2008-2011), Vice Dean (2005-2008) Professor Müller's research focuses on selective attention within and between sensory modalities, with particular emphasis on how the human perceptual system processes incomplete yet extensive streams of sensory information. His work primarily employs EEG experiments to investigate attention mechanisms. His current research interests include neural dynamics of attentional resource allocation, alpha-band fluctuations in attention processes, visual search performance, and the interaction between visuospatial and feature-based attention. Analysis of his recent publications reveals a strong focus on the neural mechanisms underlying attention processes, particularly using EEG methodology. His work consistently examines how attention modulates neural activity in the visual cortex, with recent studies investigating emotional scene processing, spatial attention mechanisms, visual search paradigms, and the relationship between motor activity and visual processing. Professor Müller has received multiple research grants from the German Research Foundation (DFG), with current projects running through 2027. His research portfolio includes studies on signal suppression hypothesis, neural dynamics of distraction, temporal neural dynamics of amplification and suppression, and attention shifting mechanisms. As an educator, Professor Müller teaches General Psychology courses focusing on attention, learning, memory, emotion, and motivation, with special emphasis on cognitive neuroscience perspectives. His teaching methodology incorporates EEG, fMRI, PET, and brain stimulation techniques.
Dr. DERYA DENİZ KANAN serves as a Lecturer in the Department of Physiology within the Faculty of Medicine at Niğde Ömer Halisdemir University since 2017. Previously, she held a Lecturer position at Toros University's Medical Services and Techniques Department from 2014-2017. Her academic journey includes dual doctorates in Physiology from Erciyes University (2006-2011) and Çukurova University (2005-2006), along with multiple master's degrees in Pharmacology and Biology Education. Her research spans neuroscience, physiology, and pharmacology with particular focus on epilepsy models, Alzheimer's disease mechanisms, and neurodegenerative processes. Key interests include: Behavioral changes in experimental disease models Exosome roles in neurodegenerative conditions Sex differences in neurological responses Cognitive function assessment in animal models Analysis of her 15 most recent publications reveals consistent investigation of neurological disorders using rat models, with increasing focus on molecular mechanisms like exosomes and gene-related pathways in recent years. Current research projects include: Investigation of gender effects on brain histopathology in aluminum chloride-induced Alzheimer's models (2021-present) TUBITAK-supported Applied Basic Cell Culture Techniques Course (2024-present) Completed studies on fermented pollen effects in schizophrenia models and Hypericum perforatum efficacy in Alzheimer's disease She has contributed to textbook chapters including 'Neurotransmitters' (2018) and 'Physiology of Nervous System' (2016), and co-edited 'Human Physiology for Health Sciences and Higher Schools' (2023).
Brian Schmit, PhD is a Professor and Hammes Family Endowed Chair in the Department of Biomedical Engineering at Marquette University, with a joint appointment at Medical College of Wisconsin. He serves as Associate Dean for Research in the OPUS College of Engineering and is an active researcher in neurological rehabilitation. Dr. Schmit's research focuses on neurophysiology of movement control following neurological injury, particularly spinal cord injury and stroke. His work encompasses biomechanics of gait and balance, diffusion tensor imaging applications in spinal cord disorders, and development of novel rehabilitation interventions including virtual reality and electrical stimulation approaches. With over 200 publications, his research has significantly contributed to understanding motor control mechanisms and developing evidence-based rehabilitation strategies. Analysis of his recent publications (2023-2025) reveals continued focus on advanced neuroimaging techniques, particularly diffusion MRI applications in spinal cord injury and stroke. His work increasingly integrates virtual reality approaches with traditional rehabilitation methods, and explores the relationship between cerebral oxygenation, hemodialysis, and cognitive function. His research maintains strong clinical relevance while applying sophisticated engineering principles to complex neurological problems. Outstanding Researcher Award, Marquette University College of Engineering (2005, 2017) Way-Klingler Science Fellowship (2008) College of Fellows, American Institute for Medical and Biological Engineering (2018) Outstanding Graduate Educator, Medical College of Wisconsin (2019) Hammes Family Endowed Chair in Biomedical Engineering (2020) Dr. Schmit currently leads or collaborates on multiple NIH-funded projects totaling several million dollars, focusing on locomotor recovery post-stroke, advanced MRI of spinal cord injury, and ischemic conditioning approaches to improve motor function. His research group includes collaborators from multiple institutions and disciplines, reflecting the interdisciplinary nature of his work. As Associate Dean for Research, he also plays a key role in shaping the research direction of Marquette's engineering college while maintaining an active laboratory focused on neurological rehabilitation.
Dr. Samira Bouyagoub is a Research Fellow II at the Clinical Imaging Sciences Centre (CISC) within Brighton and Sussex Medical School (BSMS) and holds an affiliation with the School of Psychology at the University of Sussex. She is part of the MRI Physics group led by Prof. Mara Cercignani and has been at BSMS since February 2015. Dr. Bouyagoub's research focuses on quantitative MRI, particularly diffusion MRI which measures microstructural properties of tissue. She develops multimodal tissue modeling approaches by combining diffusion MRI and relaxometry to better understand changes in brain tissue properties. Her publication record shows expertise in applying these techniques to various neurological conditions including dementia, multiple sclerosis, ALS, and Tourette syndrome. Recent work (2023-2025) spans from microstructural changes in ALS patients to cerebral function parameters in HIV patients with insomnia. She is actively involved in research funding, currently participating in the CLIMB-ALS study funded by the Motor Neurone Disease Association and a study on anxiety in joint hypermobility funded by MQ TRANSFORMING MENTAL HEALTH. Her technical expertise extends to providing software and hardware support for fMRI research equipment at CISC. Dr. Bouyagoub contributes to teaching through student-selected components in Neuroscience and Behaviour, Academic Skills for first-year students, and an Anatomy and Physics module in the MSc Clinical Radiology program, demonstrating her commitment to training the next generation of medical professionals and researchers.
Vitoria Piai is a Principal Investigator specializing in language function and dysfunction at the Donders Institute for Brain, Cognition, and Behaviour, Radboud University in Nijmegen, Netherlands. With over 135 publications and 2,595 citations, her research focuses on the neural mechanisms underlying language production using electrophysiological methods including EEG and MEG. Dr. Piai's research interests center on speech production, particularly examining the temporal dynamics of lexical and phonological processing. Her work investigates how brain oscillations relate to different stages of speech planning, how cognitive control mechanisms operate during language production, and how language networks adapt following brain damage. She employs various paradigms including picture-word interference, context-driven word production, and sentence comprehension tasks to explore these questions. Analysis of her recent publications (2024-2025) reveals consistent focus on neural oscillations during speech production, particularly examining alpha and beta band activity. Her work increasingly bridges cognitive neuroscience with clinical applications, investigating language production in aging populations, individuals with aphasia, and those with neurological conditions. She frequently employs multimodal approaches, combining behavioral measures with electrophysiological recordings to provide comprehensive insights into language processing. Dr. Piai has established significant research collaborations across institutions, particularly with colleagues at Radboud University, University of California Berkeley (where she completed postdoctoral work), and various clinical centers. Her work contributes to both theoretical understanding of language production mechanisms and practical applications for language assessment and rehabilitation.
Dr. Jan Mathijs Schoffelen serves as Associate Principal Investigator at Radboud University's Donders Institute for Brain, Cognition and Behaviour, where he leads research on brain connectivity using MEG and EEG methodologies. He represents the Norris PI group in the DCCN Representative Council and is a core developer of the globally adopted FieldTrip open-source analysis toolbox, contributing to major initiatives including the Human Connectome Project and MOUS. His research centers on neural synchronization mechanisms during cognitive processes, particularly investigating how brain rhythms facilitate inter-regional communication in language tasks. He addresses critical challenges in non-invasive electrophysiology including signal-to-noise optimization and source reconstruction validity, advancing methods to interpret neural interactions in healthy human cognition where invasive techniques are impossible. Publications reveal consistent focus on gamma-band coherence in sensorimotor systems, attentional modulation through synchronization, and computational frameworks for connectivity analysis. His work bridges theoretical neuroscience with practical tool development, demonstrating growing emphasis on language processing applications alongside foundational motor and visual system investigations. Scientific recognition includes: Young investigator award at Biomag conference, Sapporo (2008) NWO VIDI-grant for independent research leadership (2015) As Principal Investigator, he directs the FieldTrip project while contributing to large-scale collaborations like the Human Connectome Project. His NWO VIDI grant supports methodological innovations for non-invasive connectivity analysis, enabling new investigations into cognitive neuroscience. Embedded within the Donders Institute's Norris research group, he collaborates through the international FieldTrip community to advance electrophysiological analysis standards, maintaining active development of open-source tools that serve thousands of neuroscientists worldwide.
Mark J. Burish, MD, PhD, is an Assistant Professor in the Department of Neurosurgery at McGovern Medical School, UTHealth Houston, and Director of the Will Erwin Headache Research Center. He holds board certifications in neurology and pain medicine. His clinical practice focuses on neck/back pain, neuropathic conditions, and headache disorders, with research centered on circadian mechanisms of headache disorders and neuroplasticity. Education & Training: MD/PhD: Vanderbilt University (2008-2010) Residency: Neurology, University of California, San Francisco Fellowship: Interventional Pain Management, UCSF Research Interests: Dr. Burish investigates circadian biology’s role in headache disorders (cluster headache, migraine), neuropathic pain pathways, and cortical reorganization after spinal cord injuries using primate models and clinical data. His lab studies the suprachiasmatic nucleus's involvement in pain chronobiology. Publication Trends: His 15 most recent articles (2004-2015) reveal a focus on neurophysiology, cortical plasticity, pain mechanisms, and translational neurology. Key themes include sensory processing in primates, spinal cord injury recovery, and clinical neurology case studies. Awards: Alpha Omega Alpha Honor Medical Society Core Clerkship Teaching Award (UCSF) Clinical & Research Leadership: Dr. Burish leads the Will Erwin Headache Research Center, where he develops models for circadian headache research and collaborates with biochemistry experts. He also conducts clinical trials for headache treatments.
Harith Akram serves as an Honorary Clinical Associate Professor and Honorary Senior Research Fellow in the Clinical and Movement Neurosciences department at University College London. As a certified neurosurgeon specializing in functional neurosurgery and deep brain stimulation, he maintains active clinical practice alongside his academic work, as evidenced by his doctors.org.uk email address. Dr. Akram's research focuses on developing translational methods in diffusion and functional MRI brain connectivity to improve the safety and efficacy of neurosurgical interventions. His work spans multiple domains including Parkinson's disease, dystonia, essential tremor, laryngeal dystonia, and neuro-oncology applications. He has made significant contributions to understanding brain connectivity patterns relevant to movement disorders and brain tumors. Analysis of his recent publication record (2023-2025) reveals a strong focus on deep brain stimulation techniques, brain connectivity mapping, and novel applications of imaging in functional neurosurgery. His work demonstrates increasing sophistication in targeting approaches, with publications on directional DBS leads, FAT1-weighted MRI guidance, and network-based targeting for various conditions. Several high-impact papers have emerged from his research, including a Nature Neuroscience publication on mapping dysfunctional circuits in the frontal cortex using DBS. Dr. Akram appears deeply engaged in both clinical innovation and surgical education, with publications addressing anatomical accuracy in surgical nomenclature and methods for optimizing surgical efficiency. His collaborative approach is evident in numerous multicenter studies across different neurological conditions. His clinical and research activities support Sustainable Development Goal 3 (Good Health and Well-Being), with particular emphasis on improving neurological care through advanced neurosurgical techniques and precision targeting based on individual brain connectivity patterns.
Dr. Anders Borgkvist is a Principal Researcher at the Department of Neuroscience, Karolinska Institutet, where he leads the Anders Borgkvist group . His research focuses on molecular and circuit-level mechanisms in neurodevelopmental and neurodegenerative disorders, with emphasis on dopamine signaling, synaptic plasticity, and basal ganglia pathophysiology. Research Interests: Dr. Borgkvist's work spans Parkinson's disease, autism spectrum disorders, and neuropharmacology. Key areas include: Dopamine-serotonin/acetylcholine cotransmission in striatonigral pathways Synaptic filtering and plasticity in motor sensitization mTOR/autophagy dysregulation in neurodevelopment KCC2-mediated GABAergic inhibition in Parkinsonian motor deficits Grants: Swedish Research Council (2025–2028): Targeting dysregulated basal ganglia output in Parkinson’s disease (investigating KCC2 enhancement as therapy). Swedish Research Council (2017–2020): Synaptic plasticity at dopamine synapses in motor cortex during motor learning . Swedish Research Council (2009–2011): Optical studies on synaptic mechanisms of learning and addiction . His lab utilizes cutting-edge techniques including in vivo fiber photometry, GCaMP imaging, and transgenic models to dissect neural circuit dysfunctions. Collaborations include international experts in neurochemistry and movement disorders.
Prof. Dr. Til Ole Bergmann is Professor of Neurostimulation and Deputy Head of the Neuroimaging Center (NIC) at Johannes Gutenberg University Medical Center Mainz, Germany, and Research Group Leader at the Leibniz Institute for Resilience Research (LIR). His dual affiliation bridges clinical neuroscience and resilience research. Education includes: Diploma in Psychology from University of Kiel (2000-2005) Dr. phil. in Psychology (summa cum laude, 2010) Research focuses on multimodal neurostimulation techniques (TMS, tES, TUS) combined with neuroimaging (EEG, MEG, fMRI) to investigate neural oscillations during sleep and wakefulness. Key interests include real-time EEG-triggered stimulation, memory consolidation mechanisms, and developing open-source tools like BEST-Toolbox and PlanTUS for reproducible neuroscience. His work emphasizes causal inference in cognitive neuroscience through brain state-dependent stimulation paradigms. Publication trends show consistent focus on methodological innovation in neurostimulation, particularly transcranial ultrasound (TUS) development and artifact mitigation, closed-loop stimulation systems, and establishing consensus guidelines for combined TMS-fMRI applications. Awards and honors: John Rothwell Award (2021) for contributions to non-invasive brain stimulation Advising includes doctoral candidates Maximilian Lueckel (TUS-fMRI connectivity) and Sandra Schwarz (personalized rTMS for depression). Major grants: DFG (IADS) EIC Pathfinder (CITRUS) MWG (ACCESS) Leibniz (NanoBrain) Boehringer Ingelheim Stiftung (2018-2023) Leads the Neurostimulation Group with international collaborators at Stanford, UCL, Copenhagen, and Toronto focusing on deep-brain targeting and robotized neuronavigation.
Gavin R Rumbaugh is a Professor in the Department of Neuroscience at Scripps Research/UF Scripps, where he leads the Rumbaugh Laboratory. His research focuses on molecular and genetic mechanisms that shape synapse and circuit biology within the mammalian nervous system, with particular emphasis on understanding how neurodevelopmental disorder genes impact cognitive processing and behavioral adaptation. Dr. Rumbaugh's laboratory employs cutting-edge technologies to investigate how mutations in genes like SYNGAP1 disrupt neural circuit function and contribute to conditions such as autism spectrum disorder. Dr. Rumbaugh received his Ph.D. in Biophysics and Pharmacology from Georgetown University in 2000, followed by a postdoctoral fellowship at Johns Hopkins School of Medicine (2000-2006) under Richard Huganir. His academic career at Scripps Research progressed from Assistant Professor (2010-2012), to Associate Professor (2012-2019), and currently Professor (2019-present). He also served as an Adjunct Assistant Professor at the University of Alabama at Birmingham (2006-2009). The Rumbaugh laboratory investigates how major neurodevelopmental risk genes disrupt synapse function and circuit connectivity through three collaborative working groups: the Neuronal Cell Biology Group (focusing on molecular mechanisms within neuronal subtypes), the Systems Neurobiology Group (using rodent models to understand neural circuit connectivity), and the Small Molecule Discovery Group (seeking drug-like molecules to regulate gene expression). Research employs advanced techniques including Neuropixels, two-photon microscopy, patch clamp, DeepLabCut, whole-brain software, high-throughput screening, and miniscope imaging to study neural circuits and develop potential therapeutic interventions. Dr. Rumbaugh's publication record demonstrates consistent focus on SYNGAP1-related mechanisms in neurodevelopmental disorders, with recent work exploring cortical sensorimotor dynamics, synaptic plasticity, and therapeutic approaches. His research shows a clear trajectory from basic molecular mechanisms to translational applications, with increasing emphasis on circuit-level understanding and potential therapeutic interventions for neurodevelopmental conditions. Dr. Rumbaugh has received numerous prestigious awards: Member of National Advisory Mental Health Council (2024, NIMH) Kavli Fellow, Frontiers of Science (2015-2019) NARSAD Faculty Research Award (2009) Alabama Health Sciences Foundation Scholar (2006) National Research Scholar Award (2002) Multiple Faculty of 1000 Selections recognizing significant contributions As Principal Investigator, Dr. Rumbaugh oversees multiple NIH-funded research projects totaling millions of dollars. His current grants focus on synaptic actin-myosin dynamics, control of synaptic circuits, precision therapy development for monogenic mental health disorders, and understanding the impact of autism genetic risk on cortical sensorimotor dynamics. The laboratory maintains strong collaborations with the Miller Lab at Scripps Florida, as well as researchers at Johns Hopkins, Baylor College of Medicine, Max Planck Florida Institute, and other institutions, combining expertise from basic scientists, clinicians, and families of patients with neurodevelopmental disorders.
